TCL Archive NCI Proposes Extension Of Breast Cancer Screening To Determine Efficacy Of Biennial Tests November 7, 1975
TCL Archive Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve. April 13, 2007
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive NCI Boosts Funding For Cooperative Groups by $25 Million, Cuts Overall Accrual by 20 Percent, to 20,000 Patients November 11, 2011
